H.C. Bucher

Discipline

Economies et finances (4) Sociologie (1)

Type de document

Articles (28)

Co-auteur

Date

Source

Mot-clé

cohorte (23) Human beings (18) Patients (17) Patients (17) Swiss (16) Treatment (14) Ci (Chinese poetry) (13) thérapie (10) risque (10) procès (10) Therapeutics (10) Risk (10) Confidence (10) Methods (9) Methods (9) virus (8) analyse (8) Use (8) Analysis (8) temps (durée) (7) recherche (7) information (7) adulte (7) Reporting (7) Trials (7) Time (7) Research (7) Manufacturers' agents (7) Commission merchants (7) Research (7)

Documents écrit par H.C. Bucher (28) | parle de H.C. Bucher (0)

Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2).
A. Griessbach et al.
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2).
A. Griessbach et al.
CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study.
F. Chammartin et al. (15 déc. 2022)
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial.
B. Speich et al. (24 août 2022)
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients.
K. Kusejko et al. (28 juil. 2022)
Cardiovascular risk assessment in people living with HIV compared to the general population.
B. Delabays et al. (30 mars 2022)
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.
B. Speich et al. (21 oct. 2021)
Cysteine-Rich Angiogenic Inducer 61 Improves Prognostic Accuracy of GRACE (Global Registry of Acute Coronary Events) 2.0 Risk Score in Patients With Acute Coronary Syndromes.
R. Klingenberg et al. (19 oct. 2021)
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events.
R. Klingenberg et al.
Prospective validation of classification of intraoperative adverse events (ClassIntra): international, multicentre cohort study.
N.V. Gomes et al. (25 août 2020)
Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study.
C. Béguelin et al.
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis.
T. Turk et al. (12 sept. 2017)
Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials.
B. Kasenda et al. (2016)
Increases in condomless sex in the Swiss HIV Cohort Study.
R.D. Kouyos et al. (2015)
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study : changes in treatment uptake and outcomes between 1991 and 2013
G. Wandeler et al. (2015)
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study.
J. Young et al. (2015)
Planning and reporting of quality-of-life outcomes in cancer trials.
S. Schandelmaier et al. (2015)
Subgroup analyses in randomised controlled trials: cohort study on trial protocols and journal publications.
B. Kasenda et al. (16 juil. 2014)
Prevalence, characteristics, and publication of discontinued randomized trials.
B. Kasenda et al. (2014)
Obesity trends and body mass index changes after starting antiretroviral treatment : the Swiss HIV Cohort Study
B. Hasse et al. (2014)
Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort.
M.T. Koller et al. (2013)
Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study.
V. von Wyl et al. (2013)
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
M. Rotger et al. (2013)
Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study.
A. van Sighem et al. (2012)
Learning from failure - rationale and design for a study about discontinuation of randomized trials (DISCO study).
B. Kasenda et al. (2012)

next